Recently, a NF1 patient treated with tofacitinib, a selective JAK1/JAK3 inhibitor that regulated neurofibromas growth179, as well as their progression to MPNST, has been described159. The gene discussed is NF1; the disease is malignant peripheral nerve sheath tumor.